Certara Launches Fellowship Program in Africa for Applied Pharmacometrics Training
PRINCETON, N.J.— November 8, 2021 -- Certara, Inc, a global leader in biosimulation, today announced…
CertaraNovember 8, 2021
Developing Targeted Covalent Inhibitor Drugs: 3 Key Considerations
Traditional mechanisms of drug action rely on the reversible, noncovalent interaction of a ligand with…
CertaraNovember 5, 2021
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category PRINCETON, NJ…
CertaraOctober 25, 2021
Accelerating ADCs’ development pipeline using Simcyp PBPK
With nearly 10 million deaths in 2020 and despite great progress, cancer remains the leading…
CertaraOctober 15, 2021
External Control Arms – The Case for a Standardized Lexicon and Toolkit
Both the FDA and EMA have made statements that support the concept of using real…
CertaraOctober 12, 2021
A Day in the Life of a Clinical Pharmacology Consultant
Strategic consulting within drug discovery and development is an exciting career choice for many. Unlike…
CertaraOctober 8, 2021
